Issue |
J Extra Corpor Technol
Volume 37, Number 2, June 2005
|
|
---|---|---|
Page(s) | 153 - 156 | |
DOI | https://doi.org/10.1051/ject/200537153 | |
Published online | 15 June 2005 |
Scientific Article
Can Lean Body Mass Be Used to Reduce the Dose of Heparin and Protamine for Obese Patients Undergoing Cardiopulmonary Bypass?
* Department of Perfusion, Nottingham City Hospital, Nottingham, United Kingdom
† Department of Anaesthesia, Nottingham City Hospital, Nottingham, United Kingdom
‡ Department of Cardiac Surgery, Nottingham City Hospital, Nottingham, United Kingdom
Address correspondence to: Mya S. Baker, AACP, Department of Clinical Perfusion, Theatre 4, Main Theatres, Nottingham City Hospital NHS Trust, Hucknall Road, Nottingham, NG5 1PB, United Kingdom, chief_perfusionist@yahoo.com
Increasing numbers of obese patients are presenting for cardiac surgery. The convention for heparin dose dictates that a bolus of 300 IU heparin per kilogram of total body weight (TBW) is administered before CPB. During CPB, the activated clotting time (ACT) is maintained for longer than 480 seconds. At the end of the procedure, protamine is administered to neutralize heparin and achieve hemostasis. Both of these drugs can have serious side effects: heparin can induce thrombocytopenia, and protamine has been known to cause reactions in patients allergic to fish, vasectomized men, and some patients with insulin-dependent diabetes. The calculation of lean body mass (LBM) may be a more accurate method of determining drug doses as opposed to TBW and may avoid giving obese patients a relative overdose of heparin, which must subsequently be neutralized with protamine. LBM can be determined by different methods. This study used bio-electrical impedance analysis as a simple, quick, and accurate method of calculating LBM. A comparison was made between two groups of patients whose body mass index (BMI) was >27 kg/m2: Group 1, n _ 13, mean BMI _ 32, mean body fat _ 36% received the conventional dose of 300 IU/kg heparin for their TBW. Group 2, n _ 14, mean BMI _ 31, mean body fat _ 35% received a dose of 300 IU/kg heparin for their calculated LBM. ACT was conducted before and after heparin administration. Additional heparin was administered as required to achieve target ACT > 400 s. Mean ACT results and total heparin doses were analyzed using unpaired two tailed t tests. Our results indicate that with care, a reduction of as much as 25% in the doses of heparin (p_0.0001) and protamine can be achieved for a substantial number of patients classified as overweight or obese.
Key words: obesity / cardiopulmonary bypass / hemotasis / lean body mass / bio-electrical impedence / heparin / protamine
© 2005 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.